)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Karyopharm Therapeutics
Karyopharm Therapeutics (KPTI) investor relations material
Karyopharm Therapeutics EGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.EGM 2026 summary18 Feb, 2026
Opening remarks and agenda
Meeting called to order at 9:00 A.M. Eastern Time on February 18, 2026, in a virtual format, ensuring stockholders' participation rights.
Michael Mano appointed as secretary and inspector of election; oath taken and filed with meeting minutes.
Rules of conduct for participation and question submission outlined at the start.
Specific resolutions to be voted on
Proposal One: Amendment to increase authorized capital stock from 58,333,333 to 111 million and common stock from 53,333,333 to 106 million.
Proposal Two: Approval to adjourn the meeting if more time is needed for proxy solicitation regarding Proposal One.
Q&A with stakeholders
Stockholders invited to submit questions online, limited to the proposals.
No questions were submitted regarding the proposals.
New authorized capital stock limit?
Why approve Proposal 2 if Proposal 1 passed?
When will final voting results be filed?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Karyopharm Therapeutics
- 2025 revenue reached $146.1M; net loss widened to $196.0M; pivotal trial data due in 2026.KPTI
Q4 202512 Feb 2026 - Q2 2024 net income reached $23.8M on $42.8M revenue, aided by a $44.7M debt gain.KPTIQ2 20242 Feb 2026
- Selinexor shows robust efficacy in p53 wild-type endometrial cancer, with pivotal data due in 2025.KPTIJefferies 2024 Global Healthcare Conference1 Feb 2026
- Transformative phase III data in myelofibrosis, endometrial cancer, and myeloma expected by 2026.KPTIH.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026
- SENTRY Phase 3 adopts Absolute TSS as co-primary endpoint, with strong early efficacy data.KPTIStudy Update17 Jan 2026
- Q3 2024 revenue grew to $38.8M, with strong XPOVIO demand and funding risks ahead.KPTIQ3 202416 Jan 2026
- Selinexor combinations show robust efficacy and safety, with pivotal data expected in 2025.KPTIPiper Sandler 36th Annual Healthcare Conference12 Jan 2026
- Shareholders to vote on doubling authorized shares to enable future capital and strategic actions.KPTIProxy Filing9 Jan 2026
- Shareholders to vote on doubling authorized shares to support future capital needs and flexibility.KPTIProxy Filing30 Dec 2025
Next Karyopharm Therapeutics earnings date
Q1 202611 May, 2026
Karyopharm Therapeutics
Next Karyopharm Therapeutics earnings date
Q1 202611 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage